As the health delivery landscape in the United States evolves in a post-COVID-19 era, both incumbents and new entrants are reimagining models of care. Technology and medical advancements are transforming the way care is delivered and experienced, and changes in regulations and incentives across the industry are redefining how the healthcare system works and interacts. As a result, care delivery is undergoing several transformations: from sick care to preventative whole-person care, from intermittent to continuous care, from facility-based settings to omnichannel offerings through virtual care and video or telephonic technologies, and from standardized to personalized solutions. In addition to healthcare providers, payers are also redefining their role in care delivery through provider ownership, technology, and provider enablement to deliver higher-value care to members. While the payer community has been slow to innovate, they now have an opportunity and an incentive to play an active role in reimagining the future of care delivery. In the past year alone, significant disruptors have entered the provider space threatening the existence of payers, specifically self-funded programs such as Amazon and Walmart. This has served as a giant wake-up call that healthcare has shifted. Now, more than ever, there is an emphasis on the patient and clinician experience. Perhaps hastened by the pandemic, the race is on for innovations from the payer community to improve patient and provider engagement. Unlike other players, payers have end-to-end visibility into individual care needs and utilization patterns across providers and settings. This perspective can provide informed choices around optimal care models, unlock value through improved health outcomes, and lower the total cost of care for members and customers. This book is loaded with numerous case studies and interviews with healthcare leaders from the payer community, helping stakeholders understand how to leverage innovation leading them to superior business and clinical outcomes. The book also discusses how and why data is key to innovation activities and how partnerships are key to using data effectively.

Everyone talks innovation and we can all point to random examples of innovation inside of healthcare information technology, but few repeatable processes exist that make innovation more routine than happenstance. How do you create and sustain a culture of innovation? What are the best practices you can refine and embed as part of your organization’s DNA? What are the potential outcomes for robust healthcare transformation when we get this innovation mystery solved? Through timely essays from leading experts, the first edition showcased the widely adopted healthcare innovation model from HIMSS and how providers could leverage to increase their velocity of digital transformation. Regardless of its promise, innovation has been slow in healthcare. The second edition takes the critical lessons learned from the first edition, expands and refreshes the content as a result of changes in the industry and the world. For example, the pandemic really shifted things. Now providers are more ready and interested to innovate. In the past year alone, significant disruptors (such as access to digital health) have entered the provider space threatening the existence of many hospitals and practices. This has served as a giant wake-up call that healthcare has shifted. And finally, there is more emphasis today than before on the concept of patient and clinician experience. Perhaps hastened by the pandemic, the race is on for innovations that will help address clinician burnout while better engaging patients and families. Loaded with numerous case studies and stories of successful innovation projects, this book helps the reader understand how to leverage innovation to help fulfill the promise of healthcare information technology in enabling superior business and clinical outcomes.

A compilation of 3M voices, memories, facts and experiences from the company's first 100 years.

This book is a reference guide for healthcare executives and technology providers involved in the ongoing digital transformation of the healthcare sector. The book focuses specifically on the challenges and opportunities for health systems in their journey toward a digital future. It draws from proprietary research and public information, along with interviews with over one hundred and fifty executives in leading health systems such as Cleveland Clinic, Partners, Mayo, Kaiser, and Intermountain as well as numerous technology and retail providers. The authors explore the important role of technology and that of EHR systems, digital health innovators, and big tech firms in the ongoing digital transformation of healthcare. Importantly, the book draws on the accelerated learnings of the healthcare sector during the COVID-19 pandemic in their digital transformation efforts to adopt telehealth and virtual care models. Features of this book: Provides an understanding of the current state of digital transformation and the factors influencing the ongoing transformation of the healthcare sector. Includes interviews with executives from leading health systems. Describes the important role of emerging technologies; EHR systems, digital health innovators, and more. Includes case studies from innovative health organizations. Provides a set of templates and frameworks for developing and implementing a digital roadmap. Based on best practices from real-life examples, the book is a guidebook that provides a set of templates and frameworks for digital transformation practitioners in healthcare.

This book explores an organic vision of company innovation, through an analogy with DNA and its four nitrogenous bases. Like all living organisms, a company has the fundamental "genetic" bases of its ability to innovate. This DNA mutates under both environmental influences and evolutionary factors allowing a company to develop new patterns of behaviour. At the dawn of the 21st century, the result of this process is the emergence of what we could call the hyperconnected company. Through this ongoing metaphor, the book provides decision-makers with several paths along which to increase their ability to innovate, taking advantage of genetic bases such as their own factors of change. The study is based on observations made of large companies, for whom innovation is an absolute imperative. It alternates theoretical analyses with concrete illustrations, and spotlights innovation leaders such as: Louis Vuitton, 3M, Bouygues Telecom, BNP Paribas, Siemens, Danone, Air Liquide, to name but a few.

Learn and innovate with the latest technologies in nursing and healthcare! The first text of its kind in nursing, this book provides up-to-date information on innovative, smart technologies that nurses can use in clinical and nonclinical settings to keep up with the changing face of healthcare. This compelling guide will provide you with information about exciting areas of technology that have great potential to improve patient care. Subjects include big data, artificial intelligence, virtual and augmented realities, connected technologies, and precision health. There is also discusson of the shift of healthcare delivery into the community, with an outlook on improving outcomes and enhancing practice. Each chapter focuses on developing competency in current and future real-world applications of emerging technologies. Early chapters describe how to utilize new tools, processes, models, and products to serve the quadruple aim of better managing populations, decreasing costs, and enhancing both the patient’s and the clinician’s experience. The culture of innovation coincides with the ever-changing politics of healthcare in later chapters, which then evolves into the entrepreneurial opportunities for nurses. This text is an essential introduction for all practicing nurses, nurse leaders, and nurses teaching health information technology or informatics courses. Key Features: Written by nurses for nurses The latest information on emerging health information technology and associated nursing implications Compelling cases show the dramatic effect of innovations on value-based care Learn how applying novel technologies can improve patient care Qualified instructors have access to supplementary materials, including PowerPoint slides and an Instructor’s Manual

The U.S. healthcare system exists in a trust crisis. Without trust, the United States Healthcare system is doomed to mediocrity. Although healthcare is the most personal of interactions, the U.S. healthcare system is grounded in a business model based on a win-lose paradigm. Unfortunately, recent events both in society at large and within the healthcare industry have created negative trust resets(TM) that has only magnified the problem. Healthcare is unique in that it personally impacts every individual in the United States; whether being employed in the industry, an influencer such as media or government or a utilizer of healthcare services. If we are to address the challenges of access, cost and quality of healthcare we have to do more than alter payment and organizational models. We have to address the elephant in the room; trust. It will require a conscious behavior change by each stakeholder to improve trust across the system.

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.

Health-Care Solutions from a Distant Shore Health care in the United States and other nations is on a collision course with patient needs and economic reality. For more than a decade, leading thinkers, including Michael Porter and Clayton Christensen, have argued passionately for value-based health-care reform: replacing delivery based on volume and fee-for-service with competition based on value, as measured by patient outcomes per dollar spent. Though still a pipe dream here in the United States, this kind of value-based competition is already a reality--in India. Facing a giant population of poor, underserved people and a severe shortage of skills and capacity, some resourceful private enterprises have found a way to deliver high-quality health care, at ultra-low prices, to all patients who need it. This book shows how the innovations developed by these Indian exemplars are already being practiced by some far-sighted US providers--reversing the typical flow of innovation in the world. Govindarajan and Ramamurti, experts in the phenomenon of reverse innovation, reveal four pathways being used by health-care organizations in the United States to apply Indian-style principles to attack the exorbitant costs, uneven quality, and incomplete access to health care. With rich stories and detailed accounts of medical professionals who are putting these ideas into practice, this book shows how value-based delivery can be made to work in the United States. This "bottom-up" change doesn't require a grand plan out of Washington, DC, agreement between entrenched political parties, or coordination among all players in the health-care system. It needs entrepreneurs with innovative ideas about delivering value to patients. Reverse innovation has worked in other industries. We need it now in health care.

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.